| Decorin–TGFβ axis in hepatic fibrosis and cirrhosis K Baghy, RV Iozzo, I Kovalszky Journal of Histochemistry & Cytochemistry 60 (4), 262-268, 2012 | 203 | 2012 |
| Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia NG Than, R Romero, AL Tarca, KA Kekesi, Y Xu, Z Xu, K Juhasz, G Bhatti, ... Frontiers in Immunology 9, 1661, 2018 | 198 | 2018 |
| Design and development of a peptide-based adiponectin receptor agonist for cancer treatment L Otvos, E Haspinger, F La Russa, F Maspero, P Graziano, I Kovalszky, ... BMC biotechnology 11, 1-14, 2011 | 191 | 2011 |
| Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer J Tı́már, K Lapis, J Dudás, A Sebestyén, L Kopper, I Kovalszky Seminars in Cancer Biology 12 (3), 173-186, 2002 | 149 | 2002 |
| Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression A Fullár, J Dudás, L Oláh, P Hollósi, Z Papp, G Sobel, K Karászi, S Paku, ... BMC cancer 15, 1-16, 2015 | 146 | 2015 |
| Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia … NG Than, O Abdul Rahman, R Magenheim, B Nagy, T Fule, B Hargitai, ... Virchows Archiv 453, 387-400, 2008 | 144 | 2008 |
| Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer L Otvos Jr, I Kovalszky, M Riolfi, R Ferla, J Olah, A Sztodola, K Nama, ... European journal of cancer 47 (10), 1578-1584, 2011 | 124 | 2011 |
| Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar T Várkonyi, B Nagy, T Füle, AL Tarca, K Karaszi, J Schönléber, P Hupuczi, ... Placenta 32, S21-S29, 2011 | 124 | 2011 |
| Proteoglycans in liver cancer K Baghy, P Tátrai, E Regős, I Kovalszky World journal of gastroenterology 22 (1), 379, 2016 | 122 | 2016 |
| Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice K Baghy, K Dezső, V László, A Fullár, B Péterfia, S Paku, P Nagy, Z Schaff, ... Laboratory investigation 91 (3), 439-451, 2011 | 117 | 2011 |
| Placental protein 13 (PP13)–a placental immunoregulatory galectin protecting pregnancy NG Than, A Balogh, R Romero, É Kárpáti, O Erez, A Szilágyi, I Kovalszky, ... Frontiers in immunology 5, 348, 2014 | 114 | 2014 |
| Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas C Lodi, E Szabo, A Holczbauer, E Batmunkh, A Szíjártó, P Kupcsulik, ... Modern pathology 19 (3), 460-469, 2006 | 105 | 2006 |
| Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis G Lendvai, T Szekerczés, I Illyés, R Dóra, E Kontsek, A Gógl, A Kiss, ... Pathology & Oncology Research 26, 3-15, 2020 | 104 | 2020 |
| Expression of decorin, transforming growth factor-beta1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis J Dudás, I Kovalszky, M Gallai, JO Nagy, Z Schaff, T Knittel, M Mehde, ... American journal of clinical pathology 115 (5), 725-735, 2001 | 104 | 2001 |
| KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis Z Lohinai, T Klikovits, J Moldvay, G Ostoros, E Raso, J Timar, K Fabian, ... Scientific reports 7 (1), 39721, 2017 | 99 | 2017 |
| Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy M Cserepes, G Ostoros, Z Lohinai, E Raso, T Barbai, J Timar, A Rozsas, ... European journal of cancer 50 (10), 1819-1828, 2014 | 91 | 2014 |
| Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma A Fullár, I Kovalszky, M Bitsche, A Romani, VH Schartinger, GM Sprinzl, ... Experimental cell research 318 (13), 1517-1527, 2012 | 90 | 2012 |
| Distinct epidemiology and clinical consequence of classic versus rare EGFR mutations in lung adenocarcinoma Z Lohinai, MA Hoda, K Fabian, G Ostoros, E Raso, T Barbai, J Timar, ... Journal of thoracic oncology 10 (5), 738-746, 2015 | 89 | 2015 |
| Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer P Tátrai, K Egedi, Á Somorácz, TH Van Kuppevelt, G Dam, M Lyon, ... Journal of Histochemistry & Cytochemistry 58 (5), 429-441, 2010 | 89 | 2010 |
| Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma … J Dudas, G Ramadori, T KNITTEL, K NEUBAUER, D Raddatz, K EGEDY, ... Biochemical Journal 350 (1), 245-251, 2000 | 89 | 2000 |
